Sign In
Buy NWBO
$0.180
+0.0013 (+0.726%)
At Close: Jul 13, 2026
Northwest Biotherapeutics: Blinded By The Dazzle Of The Unblinding
10:00am, Sunday, 20'th Dec 2020
NWBO has run an 18-year long trial in GBM, one of the deadliest of cancers. It has been mired in controversies, and it has no cash.
Is Northwest Biotheraputics a Buy Ahead of Its Brain Tumor Vaccine Clinical Data Release?
06:15am, Wednesday, 28'th Oct 2020
In a short period of time, this immunotherapy biotech could either become a multi-bagger or trade near $0.
